SCHEMBL2608124

SCHEMBL2608124

CCCCCCc1cc(-c2ccc(-c3cc(CCCCCC)c(-c4ccc(Br)s4)s3)c3nsnc23)sc1-c1ccc(Br)s1

nearest known ligand 0.30

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.30
▸ TP53 P04637 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ ALOX5 P09917 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ TYR P14679 1/20 0.30
▸ ALOX15 P16050 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ HTT P42858 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30
▸ KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14948636 1.00 MEN1 (0.30) MEN1TP53CYP3A4ALOX5MAPT
SCHEMBL21300974 0.95 — —
SCHEMBL12610266 0.91 — —
SCHEMBL12887132 0.88 MEN1 (0.30) MEN1TP53CYP3A4ALOX5MAPT
SCHEMBL12587471 0.88 TYR (0.31) MEN1TP53CYP3A4ALOX5MAPT
SCHEMBL12982335 0.88 TYR (0.31) MEN1TP53CYP3A4ALOX5MAPT
SCHEMBL12887104 0.87 MEN1 (0.31) MEN1TP53CYP3A4ALOX5MAPT
SCHEMBL12887115 0.87 MEN1 (0.31) MEN1TP53CYP3A4ALOX5MAPT
SCHEMBL12887123 0.87 MEN1 (0.31) MEN1TP53CYP3A4ALOX5MAPT
SCHEMBL14948644 0.87 APP (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8816334-B2 N-type materials and organic electronic devices AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2014-08-26 — — US disclosed
US-8723163-B2 Organic photoelectric converter SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-05-13 — — US disclosed
US-8723163-B2 Organic photoelectric converter SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-05-13 — — US disclosed
US-20120298976-A1 N-Type Materials And Organic Electronic Devices AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2012-11-29 — — US disclosed
US-20120100285-A1 ORGANIC PHOTOELECTRIC CONVERSION ELEMENT SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-04-26 — — US disclosed
US-20120100285-A1 ORGANIC PHOTOELECTRIC CONVERSION ELEMENT SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-04-26 — — US disclosed
US-20110156018-A1 POLYMER COMPOUND AND POLYMER LIGHT-EMITTING DEVICE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-06-30 — — US disclosed
US-20110017300-A1 ORGANIC PHOTOELECTRIC CONVERTER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-01-27 — — US disclosed
US-20110017300-A1 ORGANIC PHOTOELECTRIC CONVERTER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-01-27 — — US disclosed
US-7534503-B2 Monomer for use in preparation of a polymer to be used in optical devices CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2009-05-19 — — US disclosed
US-7534503-B2 Monomer for use in preparation of a polymer to be used in optical devices CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2009-05-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110156018-A1 POLYMER COMPOUND AND POLYMER LIGHT-EMITTING DEVICE USING THE SAME CCNL2, ARL1, RIF1 MEN1 3200/4885TP53 4746/4885CYP3A4 1555/4885
US-20120298976-A1 N-Type Materials And Organic Electronic Devices NANS, DPAGT1, PNN MEN1 3456/4885TP53 2928/4885CYP3A4 2196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback